IRIS
MUSI, Gennaro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.068
EU - Europa 1.181
NA - Nord America 1.071
SA - Sud America 254
AF - Africa 59
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.637
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.065
US - Stati Uniti d'America 996
RU - Federazione Russa 704
CN - Cina 504
BR - Brasile 210
VN - Vietnam 160
HK - Hong Kong 141
IT - Italia 125
DE - Germania 94
IN - India 67
NL - Olanda 55
KR - Corea 41
FR - Francia 40
GB - Regno Unito 39
CA - Canada 33
FI - Finlandia 33
MX - Messico 27
AR - Argentina 21
BD - Bangladesh 18
ZA - Sudafrica 16
PL - Polonia 15
CI - Costa d'Avorio 14
AT - Austria 13
ID - Indonesia 11
ES - Italia 9
TR - Turchia 9
CZ - Repubblica Ceca 8
JP - Giappone 8
EC - Ecuador 7
IE - Irlanda 7
PK - Pakistan 7
IQ - Iraq 6
KE - Kenya 6
LT - Lituania 6
UA - Ucraina 6
GR - Grecia 5
SE - Svezia 5
AZ - Azerbaigian 4
EG - Egitto 4
IR - Iran 3
KG - Kirghizistan 3
MK - Macedonia 3
NA - Namibia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GM - Gambi 2
IL - Israele 2
MA - Marocco 2
NI - Nicaragua 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NE - Niger 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.635
Salva come PNG Salva come JPEG
Città #
Singapore 514
Hefei 224
Moscow 175
Hong Kong 141
Beijing 124
Ashburn 103
Chandler 100
Santa Clara 66
Amsterdam 52
Ho Chi Minh City 47
Los Angeles 47
Kochi 46
Naples 42
Seoul 40
Munich 39
Redondo Beach 29
Dong Ket 28
Hanoi 28
New York 27
Millbury 26
Buffalo 20
São Paulo 20
Dallas 19
Des Moines 18
Lawrence 18
Mexico City 17
Turku 17
Boston 16
Chicago 15
Nuremberg 15
Frankfurt am Main 13
Ottawa 13
Warsaw 13
Orem 12
Brooklyn 11
Johannesburg 11
Nanjing 10
Montreal 9
Seattle 9
Denver 8
Düsseldorf 8
Helsinki 8
Lappeenranta 8
Milan 8
Tokyo 8
Vienna 8
Atlanta 7
Bari 7
Da Nang 7
Dublin 7
London 7
Princeton 7
The Dalles 7
Wilmington 7
Poplar 6
Rome 6
Ankara 5
Brasília 5
Buenos Aires 5
Chennai 5
Dhaka 5
Houston 5
Lauterbourg 5
Nairobi 5
Napoli 5
Ninh Bình 5
Phoenix 5
Baku 4
Biên Hòa 4
Fairfield 4
Goiânia 4
Haiphong 4
Jiaxing 4
Manchester 4
Phủ Lý 4
Redwood City 4
San Francisco 4
Stockholm 4
Abidjan 3
Bengaluru 3
Betim 3
Bexley 3
Birmingham 3
Bishkek 3
Boardman 3
Bắc Giang 3
Campinas 3
Changsha 3
Dearborn 3
Formosa 3
Guarulhos 3
Islamabad 3
Karachi 3
Kolkata 3
Kronberg 3
Manaus 3
Marijampolė 3
Norwalk 3
Olomouc 3
Portsmouth 3
Totale 2.463
Salva come PNG Salva come JPEG
Nome #
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 137
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 135
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 126
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 122
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 119
Beyond PSA: The Role of Prostate Health Index (phi) 117
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 115
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 114
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 114
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 110
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 109
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 107
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 107
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 107
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 106
The impact of surgery for lower urinary tract symptoms/benign prostatic enlargement on both erectile and ejaculatory function: a systematic review 104
Prostate cancer radiogenomics—from imaging to molecular characterization 102
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 100
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study 99
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 98
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 97
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 96
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 95
Radiomics in prostate cancer: an up-to-date review 94
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 94
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 93
Telemedicine and social media: A contemporary analysis of the most shared content by internet users 92
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 91
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 85
Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field 84
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma 82
Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls 81
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy 81
Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients 81
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 77
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 74
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients 72
Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients 71
Contemporary conditional cancer‐specific survival rates in surgically treated nonmetastatic primary urethral carcinoma 64
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 63
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 62
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 62
The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients 54
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and Stage 54
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 54
The European Network for the Study of Adrenal Tumors Staging System (2015): A United States Validation 53
Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma 51
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis 49
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity 47
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients 46
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients 44
Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database Analysis 44
Total hospital cost of robot-assisted approach in major urological cancer surgeries 37
Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management 37
Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer 36
Regional differences in upper tract urothelial carcinoma patients across the United States 28
The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion 15
ASO Author Reflections: Chronic Liver Disease and Radical Cystectomy: Uncovering a Hidden Risk Factor 14
Extracorporeal vs. intracorporeal urinary diversion at robot-assisted radical cystectomy: adverse in-hospital outcomes 6
Perioperative outcomes in testicular cancer patients treated with retroperitoneal lymph node dissection 4
Adverse In-hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy 4
Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy 4
ASO Author Reflections: Adverse In-Hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy 4
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological Subtypes 4
The effect of race/ethnicity on systemic chemotherapy in urothelial carcinoma patients exposed to radiotherapy 3
Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D’amico Risk Groups in A Contemporary Cohort 3
Does Race/Ethnicity Affect Secondary Bladder and Rectal Cancer Rates After Prostate Cancer Radiation? Results from a Population-Based Study 3
Totale 4.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.674
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 13 1 1 4 0 2 31
2021/2022153 6 1 2 0 2 1 4 4 2 17 57 57
2022/2023270 25 6 11 6 43 30 0 30 44 54 19 2
2023/2024207 4 34 39 11 5 12 3 28 6 2 39 24
2024/20251.712 40 67 39 15 59 61 178 100 132 245 649 127
2025/20262.240 350 386 372 363 613 156 0 0 0 0 0 0
Totale 4.737